7716.T
Nakanishi Inc. [7716.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
7716.T Stock Summary
Top 10 Correlated ETFs
7716.T
Top 10 Correlated Stocks
7716.T
In the News
7716.T Financial details
Company Rating
Buy
Market Cap
192.98B
Income
22.84B
Revenue
59.69B
Book val./share
1325.82
Cash/share
382.38
Dividend
50
Dividend %
1.98%
Employees
2.05K
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
8.75
Forward P/E
-
PEG
1.04
P/S
4.04
P/B
1.84
P/C
5.75
P/FCF
-
Quick Ratio
2.26
Current Ratio
3.72
Debt / Equity
0.1
LT Debt / Equity
0
-
-
EPS (TTM)
268.06
EPS next Y
-
EPS next Q
-
EPS this Y
84.25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
26.74%
Revenue last 5Y
11%
Revenue Q/Q
42.58%
EPS Q/Q
-96.85%
-
-
-
-
SMA20
-2.18%
SMA50
-7.04%
SMA100
-17.09%
Inst Own
0%
Inst Trans
0%
ROA
18%
ROE
25%
ROC
0.13%
Gross Margin
64%
Oper. Margin
28%
Profit Margin
46%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1998.0-3780.0
52W High
-41.83%
52W Low
+10.06%
RSI
35.08
Rel Volume
0.9
Avg Volume
280.59K
Volume
251.5K
Perf Week
-4.18%
Perf Month
-9.73%
Perf Quarter
-33.16%
Perf Half Y
-31.71%
-
-
-
-
Beta
0.443
-
-
Volatility
43.56%, 52.27%
Prev Close
0.09%
Price
2199
Change
-2.4%
7716.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 408.78 | 381.47 | 518.31 | 567.73 | 700.65 | |
| Net income per share | 81.97 | 74.49 | 116.73 | 145.48 | 268.04 | |
| Operating cash flow per share | 81.04 | 105.98 | 138.31 | 90.57 | 100.35 | |
| Free cash flow per share | 64.28 | 92.23 | 111.14 | 44.09 | 30.48 | |
| Cash per share | 339.03 | 388.58 | 432.21 | 422.02 | 383.18 | |
| Book value per share | 836.71 | 880.17 | 958.05 | 1.06K | 1.33K | |
| Tangible book value per share | 825.59 | 867.44 | 942.55 | 1.01K | 878.37 | |
| Share holders equity per share | 836.71 | 880.17 | 958.05 | 1.06K | 1.33K | |
| Interest debt per share | 1.25 | 1.2 | 1.19 | 5.64 | 137.11 | |
| Market cap | 180.39B | 196.27B | 183.31B | 219.21B | 202B | |
| Enterprise value | 152.06B | 164.13B | 147.42B | 184.7B | 187.84B | |
| P/E ratio | 25.4 | 30.41 | 18.14 | 17.58 | 8.85 | |
| Price to sales ratio | 5.09 | 5.94 | 4.09 | 4.5 | 3.38 | |
| POCF ratio | 25.69 | 21.37 | 15.31 | 28.23 | 23.63 | |
| PFCF ratio | 32.39 | 24.56 | 19.06 | 57.99 | 77.79 | |
| P/B Ratio | 2.49 | 2.57 | 2.21 | 2.41 | 1.78 | |
| PTB ratio | 2.49 | 2.57 | 2.21 | 2.41 | 1.78 | |
| EV to sales | 4.29 | 4.97 | 3.29 | 3.79 | 3.15 | |
| Enterprise value over EBITDA | 13.44 | 15.81 | 9.42 | 9.32 | 10.59 | |
| EV to operating cash flow | 21.66 | 17.87 | 12.32 | 23.79 | 21.97 | |
| EV to free cash flow | 27.3 | 20.54 | 15.33 | 48.86 | 72.34 | |
| Earnings yield | 0.04 | 0.03 | 0.06 | 0.06 | 0.11 | |
| Free cash flow yield | 0.03 | 0.04 | 0.05 | 0.02 | 0.01 | |
| Debt to equity | 0 | 0 | 0 | 0.01 | 0.1 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0.08 | |
| Net debt to EBITDA | -2.5 | -3.1 | -2.29 | -1.74 | -0.8 | |
| Current ratio | 12.18 | 10.04 | 5.68 | 6.35 | 3.17 | |
| Interest coverage | 1.07K | 2.24K | 4.07K | 5.57K | 1.08K | |
| Income quality | 0.71 | 1.01 | 0.86 | 0.45 | 0.37 | |
| Dividend Yield | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | |
| Payout ratio | 0.39 | 0.42 | 0.27 | 0.29 | 0.18 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| Research and developement to revenue | 0.07 | 0.07 | 0.06 | 0.07 | 0.05 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.04 | 0.27 | |
| Capex to operating cash flow | -0.21 | -0.13 | -0.2 | -0.51 | -0.7 | |
| Capex to revenue | -0.04 | -0.04 | -0.05 | -0.08 | -0.1 | |
| Capex to depreciation | -0.83 | -0.66 | -1.26 | -1.89 | -1.71 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.24K | 1.21K | 1.59K | 1.86K | 2.83K | |
| ROIC | 0.09 | 0.08 | 0.12 | 0.12 | 0.09 | |
| Return on tangible assets | 0.09 | 0.08 | 0.11 | 0.13 | 0.22 | |
| Graham Net | 421.24 | 458.61 | 450.61 | 458.19 | 274.75 | |
| Working capital | 45.98B | 48.93B | 49.56B | 52.7B | 46.64B | |
| Tangible asset value | 71.53B | 75.17B | 81.57B | 86.95B | 74.83B | |
| Net current asset value | 45.06B | 48.14B | 48.61B | 51.42B | 40.63B | |
| Invested capital | 0 | 0 | 0 | 0.01 | 0.1 | |
| Average receivables | 9.48B | 9.24B | 9.49B | 8.91B | 8.25B | |
| Average payables | 895.65M | 784.54M | 908.15M | 1.27B | 1.84B | |
| Average inventory | 10.02B | 10.57B | 11.17B | 14.01B | 20.13B | |
| Days sales outstanding | 94.69 | 102.55 | 78.85 | 60.9 | 51.22 | |
| Days payables outstanding | 20.37 | 22.11 | 20.98 | 32.12 | 30.83 | |
| Days of inventory on hand | 281.67 | 290.49 | 243.85 | 340.62 | 343.28 | |
| Receivables turnover | 3.85 | 3.56 | 4.63 | 5.99 | 7.13 | |
| Payables turnover | 17.92 | 16.51 | 17.4 | 11.36 | 11.84 | |
| Inventory turnover | 1.3 | 1.26 | 1.5 | 1.07 | 1.06 | |
| ROE | 0.1 | 0.08 | 0.12 | 0.14 | 0.2 | |
| Capex per share | -16.77 | -13.75 | -27.17 | -46.47 | -69.87 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 147.21 | 159.97 | 172.33 | 151.96 | 216.4 | |
| Net income per share | 26.5 | 38.83 | 56.46 | 167.49 | 5.28 | |
| Operating cash flow per share | 14.57 | 15.42 | 16.29 | 17.48 | 32.45 | |
| Free cash flow per share | 14.57 | 15.42 | 16.29 | 17.48 | 32.45 | |
| Cash per share | 423.67 | 441.48 | 491.7 | 382.88 | 382.38 | |
| Book value per share | 1.07K | 1.09K | 1.17K | 1.37K | 1.33K | |
| Tangible book value per share | 1.02K | 1.04K | 1.12K | 962.24 | 876.53 | |
| Share holders equity per share | 1.07K | 1.09K | 1.17K | 1.37K | 1.33K | |
| Interest debt per share | 5.63 | 29.23 | 24.72 | 83.33 | 136.74 | |
| Market cap | 218.36B | 223.6B | 270.23B | 298.02B | 202.42B | |
| Enterprise value | 183.84B | 189.81B | 232.07B | 273.32B | 188.26B | |
| P/E ratio | 24.12 | 16.91 | 14.08 | 5.22 | 112.26 | |
| Price to sales ratio | 17.37 | 16.42 | 18.45 | 23 | 10.96 | |
| POCF ratio | 175.48 | 170.39 | 195.19 | 199.91 | 73.07 | |
| PFCF ratio | 175.48 | 170.39 | 195.19 | 199.91 | 73.07 | |
| P/B Ratio | 2.4 | 2.42 | 2.72 | 2.55 | 1.79 | |
| PTB ratio | 2.4 | 2.42 | 2.72 | 2.55 | 1.79 | |
| EV to sales | 14.62 | 13.94 | 15.85 | 21.09 | 10.19 | |
| Enterprise value over EBITDA | 68.2 | 41.35 | 34.89 | 65.63 | 48.84 | |
| EV to operating cash flow | 147.75 | 144.64 | 167.63 | 183.34 | 67.96 | |
| EV to free cash flow | 147.75 | 144.64 | 167.63 | 183.34 | 67.96 | |
| Earnings yield | 0.01 | 0.01 | 0.02 | 0.05 | 0 | |
| Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Debt to equity | 0.01 | 0.03 | 0.02 | 0.06 | 0.1 | |
| Debt to assets | 0 | 0.02 | 0.02 | 0.05 | 0.08 | |
| Net debt to EBITDA | -12.8 | -7.36 | -5.74 | -5.93 | -3.67 | |
| Current ratio | 6.35 | 6.82 | 6.31 | 3.72 | 3.17 | |
| Interest coverage | 15.6K | 3.22K | 5.67K | 661.28 | 421.65 | |
| Income quality | 0.55 | 0.4 | 0.29 | 0.1 | 6.15 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.02 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.11 | 0.05 | 0.06 | 0.06 | 0.05 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.26 | 0.27 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 797.18 | 973.63 | 1.22K | 2.27K | 396.87 | |
| ROIC | 0.03 | 0.03 | 0.03 | 0.03 | 0 | |
| Return on tangible assets | 0.02 | 0.03 | 0.04 | 0.14 | 0 | |
| Graham Net | 459.98 | 478.59 | 526.14 | 368.35 | 274.17 | |
| Working capital | 52.7B | 54.59B | 58.64B | 49.42B | 46.64B | |
| Tangible asset value | 86.95B | 88.32B | 95.33B | 82.05B | 74.83B | |
| Net current asset value | 51.42B | 53.33B | 57.6B | 48.27B | 40.63B | |
| Invested capital | 0.01 | 0.03 | 0.02 | 0.06 | 0.1 | |
| Average receivables | 9.06B | 7.52B | 7.25B | 7.98B | 8.38B | |
| Average payables | 1.54B | 1.69B | 1.86B | 2.18B | 2.31B | |
| Average inventory | 15.32B | 16.76B | 17.94B | 21.12B | 23.78B | |
| Days sales outstanding | 58.14 | 45.79 | 46.57 | 58.21 | 40.8 | |
| Days payables outstanding | 31.17 | 34.38 | 31.27 | 49.04 | 21.35 | |
| Days of inventory on hand | 330.53 | 322.6 | 308.43 | 467.96 | 237.71 | |
| Receivables turnover | 1.55 | 1.97 | 1.93 | 1.55 | 2.21 | |
| Payables turnover | 2.89 | 2.62 | 2.88 | 1.84 | 4.22 | |
| Inventory turnover | 0.27 | 0.28 | 0.29 | 0.19 | 0.38 | |
| ROE | 0.02 | 0.04 | 0.05 | 0.12 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
7716.T Frequently Asked Questions
What is Nakanishi Inc. stock symbol ?
Nakanishi Inc. is a JP stock and trading under the symbol 7716.T
What is Nakanishi Inc. stock quote today ?
Nakanishi Inc. stock price is $2199 today.
Is Nakanishi Inc. stock public?
Yes, Nakanishi Inc. is a publicly traded company.
Company Profile
- Volume Average 280.59K
- Market Capitalization 192.98B
- Employee 2.05K
- CEO Mr. Eiichi Nakanishi
- Headquarters Kanuma,JP
- IPO Date 2000-07-21
-
Website
https://www.nsk-nakanishi.co.jp/industrial-eng 
Nakanishi Inc. manufactures and sells dental, industrial, and medical products worldwide. The company offers turbines; clinical micromotors; contra-angles; and built-in, mobile dentistry, oral hygiene, endodontic, surgical, dental laboratory, and hygiene and maintenance products. It also offers motor spindles, and micro gridlers and tools. The company serves automotive, micromechanics, electronics, medical, die/mold, aerospace, and energy industries. Nakanishi Inc. was founded in 1930 and is headquartered in Kanuma, Japan.
